罗夫米拉斯和变化的色素性皮肤炎治疗的景观
Jimmy Dhillon1, Aryan Mahajan1, Joy Xie1
1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
The Annals of pharmacotherapy
|July 10, 2025
概括
在临床试验中,Roflumilast有效治疗斑疹性皮炎,显示显著的症状改善和有利的安全性. 进一步的研究将比较其有效性与其他可用的治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 斑疹性皮炎是一种常见的炎症性皮肤疾病.
- 固酶-4 (PDE4) 抑制剂代表了一个新的治疗类.
研究的目的:
- 审查关于roflumilast治疗斑疹性皮肤炎的临床试验数据.
- 评估roflumilast的安全性,疗效和临床效用.
主要方法:
- 关于MEDLINE (PubMed) 和clinicalTrials.gov.gov. 的文献综述,我们将在下面的文章中详细介绍.
- 包括英语文章的roflumilast的安全性,疗效,药理动力学和药理动力学.
主要成果:
- 与IIa和III期试验中的载体相比,Roflumilast在研究人员全球评估 (IGA) 中的成功率显著更高 (分别为73.8%与40.9%和79.5%与58.0%).
- 统计学上显著的红血,剥落和的严重程度的减少被观察到与roflumilast.
- 罗夫卢米拉斯特表现出耐受性良好的安全概况,副作用与汽车泡相似.
结论:
- 罗夫米拉斯特是治疗斑疹性皮肤炎的有效治疗方法.
- 它提供了积极的安全性和易于应用.
- 建议在未来进行试验,以比较roflumilast与现有疗法.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
489
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
489
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
208
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
208
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
398
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
398
COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275


